Rhythm Pharmaceuticals, Inc. (RYTM) Social Stream
RHYTHM PHARMACEUTICALS INC (RYTM) Price Targets From Analysts
Use the tables below to see what analysts covering RHYTHM PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 3 | $50 | $17 | $38 | $45.97 | -17.34% |
| 2021-11-19 | 3 | $45 | $15 | $25.666 | $45.97 | -44.17% |
| 2021-12-01 | 4 | $45 | $15 | $29.25 | $45.97 | -36.37% |
| 2021-12-08 | 5 | $45 | $15 | $29.4 | $45.97 | -36.05% |
| 2022-01-26 | 5 | $40 | $10 | $23.75 | $45.97 | -48.34% |
| 2022-02-07 | 5 | $40 | $10 | $23 | $45.97 | -49.97% |
| 2022-02-17 | 5 | $40 | $12 | $22.8 | $45.97 | -50.4% |
| 2022-02-28 | 5 | $40 | $10 | $21.4 | $45.97 | -53.45% |
| 2022-03-01 | 5 | $40 | $9 | $21.2 | $45.97 | -53.88% |
| 2022-03-02 | 6 | $40 | $9 | $21.2 | $45.97 | -53.88% |
| 2022-03-03 | 6 | $40 | $9 | $21.5 | $45.97 | -53.23% |
| 2022-04-06 | 6 | $40 | $10 | $21.666 | $45.97 | -52.87% |
| 2022-05-05 | 6 | $40 | $8 | $21.333 | $45.97 | -53.59% |
| 2022-05-06 | 7 | $40 | $7 | $21.166 | $45.97 | -53.96% |
| 2022-05-24 | 7 | $40 | $7 | $19.142 | $45.97 | -58.36% |
| 2022-06-07 | 7 | $40 | $4 | $18 | $45.97 | -60.84% |
| 2022-06-22 | 8 | $40 | $4 | $19.125 | $45.97 | -58.4% |
| 2022-08-02 | 8 | $40 | $6 | $22 | $45.97 | -52.14% |
| 2022-08-03 | 8 | $40 | $6 | $23.875 | $45.97 | -48.06% |
| 2022-08-05 | 8 | $40 | $6 | $25.5 | $45.97 | -44.53% |
| 2022-08-13 | 8 | $40 | $16 | $28.25 | $45.97 | -38.55% |
| 2022-08-23 | 8 | $40 | $16 | $28.875 | $45.97 | -37.19% |
| 2022-11-02 | 8 | $40 | $16 | $29.25 | $45.97 | -36.37% |
| 2022-11-08 | 8 | $40 | $16 | $30.5 | $45.97 | -33.65% |
| 2022-11-10 | 8 | $40 | $25 | $33 | $45.97 | -28.21% |
| 2022-12-08 | 7 | $40 | $26 | $33.25 | $45.97 | -27.67% |
| 2023-01-25 | 7 | $40 | $26 | $33.875 | $45.97 | -26.31% |
| 2023-01-26 | 7 | $40 | $26 | $34.5 | $45.97 | -24.95% |
| 2023-02-08 | 6 | $52 | $26 | $36.444 | $45.97 | -20.72% |
| 2023-03-03 | 8 | $56 | $28 | $39.9 | $45.97 | -13.2% |
| 2023-04-12 | 8 | $56 | $28 | $39.8 | $45.97 | -13.42% |
| 2023-05-02 | 8 | $56 | $28 | $39.5 | $45.97 | -14.07% |
| 2023-05-03 | 8 | $56 | $23 | $39 | $45.97 | -15.16% |
| 2023-07-25 | 8 | $52 | $23 | $38.6 | $45.97 | -16.03% |
| 2023-08-01 | 7 | $52 | $23 | $37.111 | $45.97 | -19.27% |
| 2023-08-21 | 7 | $52 | $22 | $38 | $45.97 | -17.34% |
| 2023-10-10 | 7 | $52 | $22 | $38.125 | $45.97 | -17.07% |
| 2023-10-17 | 7 | $52 | $28 | $38.875 | $45.97 | -15.43% |
| 2023-10-19 | 7 | $52 | $29 | $39.25 | $45.97 | -14.62% |
| 2023-11-07 | 7 | $70 | $29 | $44.333 | $45.97 | -3.56% |
| 2023-11-08 | 8 | $70 | $29 | $43.9 | $45.97 | -4.5% |
| 2023-12-07 | 9 | $70 | $29 | $43.333 | $45.97 | -5.74% |
| 2023-12-11 | 9 | $70 | $29 | $44.222 | $45.97 | -3.8% |
| 2023-12-19 | 9 | $70 | $31 | $47.666 | $45.97 | 3.69% |
The Trend in the Analyst Price Target
RYTM's average price target has moved up $25.44 over the prior 21 months.
Over the past 48 weeks, RYTM's average upside potential has been 70.24%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-02 | 8 | 56 | 28 | 39.500 | 18.740 | 110.78% |
| 2023-05-05 | 8 | 52 | 23 | 38.600 | 16.690 | 131.28% |
| 2023-11-08 | 9 | 70 | 29 | 43.900 | 27.415 | 60.13% |
| 2023-12-07 | 9 | 70 | 29 | 43.333 | 38.000 | 14.03% |
| 2023-12-19 | 9 | 70 | 31 | 47.111 | 46.130 | 2.13% |
RYTM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.11 | 8 | 1 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
RYTM's average broker recommendation rating improved by 0.51 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RYTM as an investment opportunity.
- RYTM has a higher upside potential (average analyst target price relative to current price) than 488.75% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, RHYTHM PHARMACEUTICALS INC's variance in analysts' estimates is lower than -4771.72% of them.
- RHYTHM PHARMACEUTICALS INC's number of analysts covering the stock is greater than 4483.8% of stocks in the small market cap category.
- In terms of how RHYTHM PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 4275.75% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RHYTHM PHARMACEUTICALS INC are URGN, GTHX, and AEZS.
View All Top Stocks by Price Target
Make investment decisions regarding RYTM using the data that counts. Try POWR Ratings for free.